Literature DB >> 19957922

Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity.

A Jonathan Singh1, Chun-Xiao Xu, Xiaoming Xu, Lyndon M West, Anja Wilmes, Ariane Chan, Ernest Hamel, John H Miller, Peter T Northcote, Arun K Ghosh.   

Abstract

Peloruside B (2), a natural congener of peloruside A (1), was isolated in sub-milligram quantities from the New Zealand marine sponge Mycale hentscheli. Peloruside B promotes microtubule polymerization and arrests cells in the G(2)/M phase of mitosis similar to paclitaxel, and its bioactivity was comparable to that of peloruside A. NMR-directed isolation, structure elucidation, structure confirmation by total synthesis, and bioactivity of peloruside B are described in this article. The synthesis features Sharpless dihydroxylation, Brown's asymmetric allylboration reaction, reductive aldol coupling, Yamaguchi macrolactonization, and selective methylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19957922      PMCID: PMC2812918          DOI: 10.1021/jo9021265

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  27 in total

1.  Toward a total synthesis of peloruside A: enantioselective preparation of the C8-C19 region.

Authors:  Richard E Taylor; Meizhong Jin
Journal:  Org Lett       Date:  2003-12-25       Impact factor: 6.005

2.  Toward the total synthesis of natural peloruside a: stereoselective synthesis of the backbone of the core.

Authors:  Bo Liu; Wei-Shan Zhou
Journal:  Org Lett       Date:  2004-01-08       Impact factor: 6.005

3.  Total synthesis and absolute configuration of the novel microtubule-stabilizing agent peloruside A.

Authors:  Xibin Liao; Yusheng Wu; Jef K De Brabander
Journal:  Angew Chem Int Ed Engl       Date:  2003-04-11       Impact factor: 15.336

4.  Stereoselective synthesis of the C(1)-C(11) fragment of peloruside A.

Authors:  Robert M Owen; William R Roush
Journal:  Org Lett       Date:  2005-09-01       Impact factor: 6.005

5.  Peloruside A: a potent cytotoxic macrolide isolated from the new zealand marine sponge Mycale sp.

Authors:  L M West; P T Northcote; C N Battershill
Journal:  J Org Chem       Date:  2000-01-28       Impact factor: 4.354

6.  Studies for the synthesis of marine natural products.

Authors:  David R Williams; Martin J Walsh; Christopher D Claeboe; Nicolas Zorn
Journal:  Pure Appl Chem       Date:  2009       Impact factor: 2.453

7.  Improved procedure for the oxidative cleavage of olefins by OsO4-NaIO4.

Authors:  Wensheng Yu; Yan Mei; Ying Kang; Zhengmao Hua; Zhendong Jin
Journal:  Org Lett       Date:  2004-09-16       Impact factor: 6.005

8.  Decarboxylative Grob-type fragmentations in the synthesis of trisubstituted Z olefins: application to peloruside A, discodermolide, and epothilone D.

Authors:  Kathrin Prantz; Johann Mulzer
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  A unique mode of microtubule stabilization induced by peloruside A.

Authors:  J Torin Huzil; John K Chik; Gordon W Slysz; Holly Freedman; Jack Tuszynski; Richard E Taylor; Dan L Sackett; David C Schriemer
Journal:  J Mol Biol       Date:  2008-03-19       Impact factor: 5.469

10.  Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.

Authors:  Kylie A Hood; Lyndon M West; Berber Rouwé; Peter T Northcote; Michael V Berridge; St John Wakefield; John H Miller
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  13 in total

1.  Total synthesis of peloruside A through kinetic lactonization and relay ring-closing metathesis cyclization reactions.

Authors:  Thomas R Hoye; Junha Jeon; Lucas C Kopel; Troy D Ryba; Manomi A Tennakoon; Yini Wang
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-16       Impact factor: 15.336

2.  A bidirectional S(E)' strategy for 1,5-syn and 1,5-anti stereocontrol toward the synthesis of complex polyols.

Authors:  David R Williams; Christopher D Claeboe; Bo Liang; Nicolas Zorn; Nicholas S C Chow
Journal:  Org Lett       Date:  2012-07-19       Impact factor: 6.005

Review 3.  Peloruside, laulimalide, and noscapine interactions with beta-tubulin.

Authors:  Melissa M Gajewski; Laleh Alisaraie; Jack A Tuszynski
Journal:  Pharm Res       Date:  2012-06-26       Impact factor: 4.200

Review 4.  Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Authors:  Carlo Ballatore; Kurt R Brunden; Donna M Huryn; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith
Journal:  J Med Chem       Date:  2012-09-28       Impact factor: 7.446

5.  Enantioselective syntheses of the proposed structures of cytotoxic macrolides iriomoteolide-1a and -1b.

Authors:  Arun K Ghosh; Hao Yuan
Journal:  Org Lett       Date:  2010-07-16       Impact factor: 6.005

Review 6.  Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

Authors:  Cristina C Rohena; Susan L Mooberry
Journal:  Nat Prod Rep       Date:  2014-03       Impact factor: 13.423

7.  Rapid access to conformational analogues of (+)-peloruside A.

Authors:  Zhiming Zhao; Richard E Taylor
Journal:  Org Lett       Date:  2012-01-11       Impact factor: 6.005

8.  Capturing the essence of organic synthesis: from bioactive natural products to designed molecules in today's medicine.

Authors:  Arun K Ghosh
Journal:  J Org Chem       Date:  2010-10-11       Impact factor: 4.354

Review 9.  Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.

Authors:  John H Miller; A Jonathan Singh; Peter T Northcote
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

10.  The assembly-inducing laulimalide/peloruside a binding site on tubulin: molecular modeling and biochemical studies with [³H]peloruside A.

Authors:  Tam Luong Nguyen; Xiaoming Xu; Rick Gussio; Arun K Ghosh; Ernest Hamel
Journal:  J Chem Inf Model       Date:  2010-10-28       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.